Short Stature in Childhood and Adolescence: Part 1: Medical management

Insights

Familial short stature and constitutional growth delay are common causes of short stature in children. Guidelines help differentiate these from pathological conditions, guiding investigation, treatment, and growth hormone therapy.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Family Medicine

Background:

  • Childhood short stature presents a common challenge in family practice.
  • Familial short stature and constitutional growth delay represent the majority of cases.

Purpose of the Study:

  • To provide clear guidelines for differentiating common causes of short stature from pathological conditions.
  • To outline appropriate investigation, treatment, and referral strategies for childhood short stature.
  • To describe the role and application of growth hormone therapy.

Main Methods:

  • Review of existing literature and clinical guidelines.
  • Delineation of diagnostic criteria for differentiating growth patterns.
  • Description of therapeutic interventions, including growth hormone therapy.

Main Results:

  • Established criteria for distinguishing familial short stature and constitutional growth delay.
  • Outlined pathways for investigation and management of short stature.
  • Detailed growth hormone therapy protocols and indications.

Conclusions:

  • A clear diagnostic and management framework exists for common causes of childhood short stature.
  • An integrated medical-psychosocial approach is recommended for comprehensive patient care.
  • Timely and accurate diagnosis is crucial for effective management and optimal growth outcomes.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...